Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning.

Le Dudal M, Huguet L, Perez J, Vandermeersch S, Bouderlique E, Tang E, Martori C, Chemaly N, Nabbout R, Haymann JP, Frochot V, Baud L, Deschênes G, Daudon M, Letavernier E.

J Clin Invest. 2019 Apr 4;130:2571-2577. doi: 10.1172/JCI99822.

2.

High prevalence of altered sudomotor function in homozygous sickle cell patients: influence of age and anaemia.

Affes Z, Lionnet F, Livrozet M, Santin A, Frochot V, Letavernier E, Lefaucheur JP, Haymann JP.

Br J Haematol. 2019 Apr 1. doi: 10.1111/bjh.15892. [Epub ahead of print] No abstract available.

PMID:
30937883
3.

Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.

Tabibzadeh N, Wagner S, Metzger M, Flamant M, Houillier P, Boffa JJ, Vrtovsnik F, Thervet E, Stengel B, Haymann JP; NephroTest Study Group.

Am J Kidney Dis. 2019 May;73(5):596-604. doi: 10.1053/j.ajkd.2018.12.024. Epub 2019 Feb 15.

PMID:
30777634
4.

Daily Green Tea Infusions in Hypercalciuric Renal Stone Patients: No Evidence for Increased Stone Risk Factors or Oxalate-Dependent Stones.

Rode J, Bazin D, Dessombz A, Benzerara Y, Letavernier E, Tabibzadeh N, Hoznek A, Tligui M, Traxer O, Daudon M, Haymann JP.

Nutrients. 2019 Jan 24;11(2). pii: E256. doi: 10.3390/nu11020256.

5.

Urothelium proliferation is a trigger for renal crystal deposits in a murine lithogenesis model.

Bilbault H, Perez J, Huguet L, Vandermeersch S, Placier S, Tabibzadeh N, Frochot V, Letavernier E, Bazin D, Daudon M, Haymann JP.

Sci Rep. 2018 Nov 5;8(1):16319. doi: 10.1038/s41598-018-34734-8.

6.

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study.

Vidal-Petiot E, Metzger M, Faucon AL, Boffa JJ, Haymann JP, Thervet E, Houillier P, Geri G, Stengel B, Vrtovsnik F, Flamant M; NephroTest study group.

J Am Heart Assoc. 2018 Oct 2;7(19):e010278. doi: 10.1161/JAHA.118.010278.

7.

Conservative three-quarter versus subtotal seven-eighths parathyroidectomy in secondary hyperparathyroidism.

Veyrat M, Fessi H, Haymann JP, Ronco P, Lacau St Guily J, Périé S.

Eur Ann Otorhinolaryngol Head Neck Dis. 2019 Apr;136(2):63-68. doi: 10.1016/j.anorl.2018.09.003. Epub 2018 Oct 13.

PMID:
30327179
8.

Performance of creatinine-based equations for estimating glomerular filtration rate changes over time.

van Rijn MHC, Metzger M, Flamant M, Houillier P, Haymann JP, van den Brand JAJG, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2018 Sep 1. doi: 10.1093/ndt/gfy278. [Epub ahead of print]

PMID:
30184233
9.

ABCC6 Deficiency Promotes Development of Randall Plaque.

Letavernier E, Kauffenstein G, Huguet L, Navasiolava N, Bouderlique E, Tang E, Delaitre L, Bazin D, de Frutos M, Gay C, Perez J, Verpont MC, Haymann JP, Pomozi V, Zoll J, Le Saux O, Daudon M, Leftheriotis G, Martin L.

J Am Soc Nephrol. 2018 Sep;29(9):2337-2347. doi: 10.1681/ASN.2017101148. Epub 2018 Jul 10.

PMID:
29991491
10.

From arterial stiffness to kidney graft microvasculature: Mortality and graft survival within a cohort of 220 kidney transplant recipients.

Cheddani L, Radulescu C, Chaignon M, Karras A, Neuzillet Y, Duong JP, Tabibzadeh N, Letavernier E, Delahousse M, Haymann JP.

PLoS One. 2018 May 3;13(5):e0195928. doi: 10.1371/journal.pone.0195928. eCollection 2018.

11.

Evaluation of a Portable Urinary pH Meter and Reagent Strips.

De Coninck V, Keller EX, Rodríguez-Monsalve M, Doizi S, Audouin M, Haymann JP, Traxer O.

J Endourol. 2018 Jul;32(7):647-652. doi: 10.1089/end.2018.0202. Epub 2018 May 29.

PMID:
29699425
12.

Cardiac manifestations in sickle cell disease varies with patient genotype.

Guedeney P, Lionnet F, Ceccaldi A, Stankovic Stojanovic K, Cohen A, Mattioni S, Montalescot G, Bachmeyer C, Isnard R, Haymann JP, Hammoudi N.

Br J Haematol. 2018 Jun;181(5):664-671. doi: 10.1111/bjh.15238. Epub 2018 Apr 20.

PMID:
29676452
13.

Association of a Low-Protein Diet With Slower Progression of CKD.

Metzger M, Yuan WL, Haymann JP, Flamant M, Houillier P, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Bankir L, Fouque D, Stengel B.

Kidney Int Rep. 2017 Aug 30;3(1):105-114. doi: 10.1016/j.ekir.2017.08.010. eCollection 2018 Jan.

14.

Iron Chelation Resulting in Renal Phosphate Wasting.

Cheddani L, Leblanc T, Silve C, Tabibzadeh N, Prié D, Haymann JP, Péraldi MN, Daudon M, Meria P, Letavernier E.

Kidney Int Rep. 2017 Jul 29;3(1):1-4. doi: 10.1016/j.ekir.2017.07.011. eCollection 2018 Jan. No abstract available.

15.

High frequency and wide range of human kidney papillary crystalline plugs.

Huguet L, Le Dudal M, Livrozet M, Bazin D, Frochot V, Perez J, Haymann JP, Brocheriou I, Daudon M, Letavernier E.

Urolithiasis. 2018 Aug;46(4):333-341. doi: 10.1007/s00240-017-1031-9. Epub 2017 Dec 12.

PMID:
29234857
16.

Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.

Haymann JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, Habibi A, Avellino V, Bartolucci P, Benzerara Y, Arlet JB, Djebbar M, Letavernier E, Grateau G, Tabibzadeh N, Girshovich A, Chaignon M, Girot R, Levy P, Lionnet F.

Br J Haematol. 2017 Dec;179(5):820-828. doi: 10.1111/bjh.14969. Epub 2017 Oct 19.

PMID:
29048108
17.

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Oct 6;18(1):308. doi: 10.1186/s12882-017-0723-2. No abstract available.

18.

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study.

Wagner S, Metzger M, Flamant M, Houillier P, Haymann JP, Vrtovsnik F, Thervet E, Boffa JJ, Massy ZA, Stengel B, Rossignol P; NephroTest Study group.

BMC Nephrol. 2017 Sep 12;18(1):295. doi: 10.1186/s12882-017-0710-7. Erratum in: BMC Nephrol. 2017 Oct 6;18(1):308.

19.

Reversal of Arterial Stiffness and Maladaptative Arterial Remodeling After Kidney Transplantation.

Karras A, Boutouyrie P, Briet M, Bozec E, Haymann JP, Legendre C, McMahon LP, Delahousse M.

J Am Heart Assoc. 2017 Sep 9;6(9). pii: e006078. doi: 10.1161/JAHA.117.006078.

20.

Specific calpain inhibition protects kidney against inflammaging.

Hanouna G, Mesnard L, Vandermeersch S, Perez J, Placier S, Haymann JP, Campagne F, Moroch J, Bataille A, Baud L, Letavernier E.

Sci Rep. 2017 Aug 14;7(1):8016. doi: 10.1038/s41598-017-07922-1.

21.

Sickle Cell Disease.

Lionnet F, Haymann JP, Bachmeyer C.

N Engl J Med. 2017 Jul 20;377(3):304. doi: 10.1056/NEJMc1706325. No abstract available.

PMID:
28723337
22.

The Case | Epistasis and urolithiasis.

Tabibzadeh N, Cheddani L, Daudon M, Haymann JP, Toussaint A, Silve C, Letavernier E.

Kidney Int. 2017 Aug;92(2):523-524. doi: 10.1016/j.kint.2017.01.026. No abstract available.

PMID:
28709611
23.

[Acute obstructive nephropathy: A pathophysiological view].

Haymann JP, Vinsonneau C, Girshovich A, Daudon M.

Nephrol Ther. 2017 Apr;13 Suppl 1:S1-S5. doi: 10.1016/j.nephro.2017.01.008. French.

PMID:
28577729
24.

Plasma heme-induced renal toxicity is related to a capillary rarefaction.

Tabibzadeh N, Estournet C, Placier S, Perez J, Bilbault H, Girshovich A, Vandermeersch S, Jouanneau C, Letavernier E, Hammoudi N, Lionnet F, Haymann JP.

Sci Rep. 2017 Jan 10;7:40156. doi: 10.1038/srep40156.

25.

[The role of physicochemistry in urology and nephrology, selected results obtained during the last ten years].

Bazin D, Letavernier E, Haymann JP, Méria P, Daudon M.

Prog Urol. 2016 Sep - Oct;26(11-12):608-618. doi: 10.1016/j.purol.2016.08.019. Epub 2016 Sep 21. Review. French.

PMID:
27665409
26.

Topography, Composition and Structure of Incipient Randall Plaque at the Nanoscale Level.

Verrier C, Bazin D, Huguet L, Stéphan O, Gloter A, Verpont MC, Frochot V, Haymann JP, Brocheriou I, Traxer O, Daudon M, Letavernier E.

J Urol. 2016 Nov;196(5):1566-1574. doi: 10.1016/j.juro.2016.04.086. Epub 2016 May 6.

PMID:
27157373
27.

Calcium and vitamin D have a synergistic role in a rat model of kidney stone disease.

Letavernier E, Verrier C, Goussard F, Perez J, Huguet L, Haymann JP, Baud L, Bazin D, Daudon M.

Kidney Int. 2016 Oct;90(4):809-17. doi: 10.1016/j.kint.2016.05.027. Epub 2016 Jul 27.

PMID:
27475231
28.

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.

Flahault A, Metzger M, Chassé JF, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E, Pallet N; NephroTest study group.

PLoS One. 2016 Jun 1;11(6):e0156433. doi: 10.1371/journal.pone.0156433. eCollection 2016.

29.

Iron restriction is an important treatment of hemoglobin SC disease.

Lionnet F, Hammoudi N, Stojanovic KS, Avellino V, Grateau G, Girot R, Haymann JP.

Am J Hematol. 2016 Jul;91(7):E320. doi: 10.1002/ajh.24380. Epub 2016 Apr 24. No abstract available.

30.

Experimental models of renal calcium stones in rodents.

Bilbault H, Haymann JP.

World J Nephrol. 2016 Mar 6;5(2):189-94. doi: 10.5527/wjn.v5.i2.189. Review.

31.

Calcium oxalate precipitation by diffusion using laminar microfluidics: toward a biomimetic model of pathological microcalcifications.

Laffite G, Leroy C, Bonhomme C, Bonhomme-Coury L, Letavernier E, Daudon M, Frochot V, Haymann JP, Rouzière S, Lucas IT, Bazin D, Babonneau F, Abou-Hassan A.

Lab Chip. 2016 Apr 7;16(7):1157-60. doi: 10.1039/c6lc00197a.

PMID:
26974287
32.

Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.

Vargas-Poussou R, Mansour-Hendili L, Baron S, Bertocchio JP, Travers C, Simian C, Treard C, Baudouin V, Beltran S, Broux F, Camard O, Cloarec S, Cormier C, Debussche X, Dubosclard E, Eid C, Haymann JP, Kiando SR, Kuhn JM, Lefort G, Linglart A, Lucas-Pouliquen B, Macher MA, Maruani G, Ouzounian S, Polak M, Requeda E, Robier D, Silve C, Souberbielle JC, Tack I, Vezzosi D, Jeunemaitre X, Houillier P.

J Clin Endocrinol Metab. 2016 May;101(5):2185-95. doi: 10.1210/jc.2015-3442. Epub 2016 Mar 10.

PMID:
26963950
33.

Vasopressin regulates renal calcium excretion in humans.

Hanouna G, Haymann JP, Baud L, Letavernier E.

Physiol Rep. 2015 Nov;3(11). pii: e12562. doi: 10.14814/phy2.12562.

34.

Calpains Released by T Lymphocytes Cleave TLR2 To Control IL-17 Expression.

Perez J, Dansou B, Hervé R, Levi C, Tamouza H, Vandermeersch S, Demey-Thomas E, Haymann JP, Zafrani L, Klatzmann D, Boissier MC, Letavernier E, Baud L.

J Immunol. 2016 Jan 1;196(1):168-81. doi: 10.4049/jimmunol.1500749. Epub 2015 Nov 25.

35.

Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion.

Verbalis JG, Greenberg A, Burst V, Haymann JP, Johannsson G, Peri A, Poch E, Chiodo JA 3rd, Dave J.

Am J Med. 2016 May;129(5):537.e9-537.e23. doi: 10.1016/j.amjmed.2015.11.005. Epub 2015 Nov 14.

PMID:
26584969
36.

Glycated Hemoglobin Level and Mortality in a Nondiabetic Population with CKD.

Trivin C, Metzger M, Haymann JP, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Stengel B, Thervet E; NephroTest Study Group.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):957-64. doi: 10.2215/CJN.08540814. Epub 2015 May 15.

37.

Urinary creatinine excretion, measured glomerular filtration rate and CKD outcomes.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

Nephrol Dial Transplant. 2015 Aug;30(8):1386-94. doi: 10.1093/ndt/gfv047. Epub 2015 Mar 27.

PMID:
25817225
38.

Demographics and characterization of 10,282 Randall plaque-related kidney stones: a new epidemic?

Letavernier E, Vandermeersch S, Traxer O, Tligui M, Baud L, Ronco P, Haymann JP, Daudon M.

Medicine (Baltimore). 2015 Mar;94(10):e566. doi: 10.1097/MD.0000000000000566.

39.

Urinary ammonia and long-term outcomes in chronic kidney disease.

Vallet M, Metzger M, Haymann JP, Flamant M, Gauci C, Thervet E, Boffa JJ, Vrtovsnik F, Froissart M, Stengel B, Houillier P; NephroTest Cohort Study group.

Kidney Int. 2015 Jul;88(1):137-45. doi: 10.1038/ki.2015.52. Epub 2015 Mar 11.

PMID:
25760321
40.

Calcium phosphate stone morphology can reliably predict distal renal tubular acidosis.

Dessombz A, Letavernier E, Haymann JP, Bazin D, Daudon M.

J Urol. 2015 May;193(5):1564-9. doi: 10.1016/j.juro.2014.12.017. Epub 2014 Dec 10.

PMID:
25498572
41.

Decrease in urinary creatinine excretion in early stage chronic kidney disease.

Tynkevich E, Flamant M, Haymann JP, Metzger M, Thervet E, Boffa JJ, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Nov 17;9(11):e111949. doi: 10.1371/journal.pone.0111949. eCollection 2014.

42.

The case: a crystal-clear diagnosis: acute kidney injury in a patient with suspected meningoencephalitis. Diagnosis: Amoxicillin-induced crystal nephropathy.

Rafat C, Haymann JP, Gaudry S, Labbé V, Miguel-Montanes R, Dufour N, Daudon M, Dreyfuss D, Ricard JD.

Kidney Int. 2014 Nov;86(5):1065-6. doi: 10.1038/ki.2013.446. No abstract available.

43.

Metabolic disorders: stones as first clinical manifestation of significant diseases.

Haymann JP.

World J Urol. 2015 Feb;33(2):187-92. doi: 10.1007/s00345-014-1391-5. Epub 2014 Sep 5.

PMID:
25189457
44.

An animal model of type A cystinuria due to spontaneous mutation in 129S2/SvPasCrl mice.

Livrozet M, Vandermeersch S, Mesnard L, Thioulouse E, Jaubert J, Boffa JJ, Haymann JP, Baud L, Bazin D, Daudon M, Letavernier E.

PLoS One. 2014 Jul 21;9(7):e102700. doi: 10.1371/journal.pone.0102700. eCollection 2014.

45.

The relation of hepcidin to iron disorders, inflammation and hemoglobin in chronic kidney disease.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Houillier P, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Jun 30;9(6):e99781. doi: 10.1371/journal.pone.0099781. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0123145. Mercadel, Lucile [corrected to Mercadal, Lucile].

46.

A 3-marker index improves the identification of iron disorders in CKD anaemia.

Mercadal L, Metzger M, Haymann JP, Thervet E, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Stengel B; NephroTest Study Group.

PLoS One. 2014 Feb 19;9(2):e84144. doi: 10.1371/journal.pone.0084144. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100606.

47.

External validation of the BIS (Berlin Initiative Study)-1 GFR estimating equation in the elderly.

Vidal-Petiot E, Haymann JP, Letavernier E, Serrano F, Clerici C, Boffa JJ, Vrtovsnik F, Flamant M.

Am J Kidney Dis. 2014 May;63(5):865-7. doi: 10.1053/j.ajkd.2014.01.421. Epub 2014 Feb 20. No abstract available.

PMID:
24560028
48.

Prevalence and correlates of metabolic acidosis among patients with homozygous sickle cell disease.

Maurel S, Stankovic Stojanovic K, Avellino V, Girshovich A, Letavernier E, Grateau G, Baud L, Girot R, Lionnet F, Haymann JP.

Clin J Am Soc Nephrol. 2014 Apr;9(4):648-53. doi: 10.2215/CJN.09790913. Epub 2014 Jan 23.

49.

[First-line screening guidelines for renal stone disease patients: a CLAFU update].

Haymann JP, Daudon M, Normand M, Hoznek A, Meria P, Traxer O; CLAFU.

Prog Urol. 2014 Jan;24(1):9-12. doi: 10.1016/j.purol.2013.06.014. Epub 2013 Jul 29. French.

PMID:
24365623
50.

Renal function can improve at any stage of chronic kidney disease.

Weis L, Metzger M, Haymann JP, Thervet E, Flamant M, Vrtovsnik F, Gauci C, Houillier P, Froissart M, Letavernier E, Stengel B, Boffa JJ; NephroTest Study Group.

PLoS One. 2013 Dec 13;8(12):e81835. doi: 10.1371/journal.pone.0081835. eCollection 2013.

Supplemental Content

Loading ...
Support Center